We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Tools
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Genuit Group Plc | GEN | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 10.50 | 3.25% | 334.00 | 16:35:07 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 325.00 | 325.00 | 337.00 | 334.00 | 323.50 |
| Industry Sector |
|---|
| INDUSTRIAL ENGINEERING |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 15/08/2023 | Interim | GBP | 0.041 | 31/08/2023 | 01/09/2023 | 27/09/2023 |
| 14/03/2023 | Final | GBP | 0.082 | 20/04/2023 | 21/04/2023 | 24/05/2023 |
| 16/08/2022 | Interim | GBP | 0.041 | 01/09/2022 | 02/09/2022 | 28/09/2022 |
| 15/03/2022 | Final | GBP | 0.082 | 21/04/2022 | 22/04/2022 | 25/05/2022 |
| 17/08/2021 | Interim | GBP | 0.04 | 02/09/2021 | 03/09/2021 | 24/09/2021 |
| 16/03/2021 | Final | GBP | 0.048 | 22/04/2021 | 23/04/2021 | 26/05/2021 |
| 20/03/2019 | Interim | GBP | 0.04 | 29/08/2019 | 30/08/2019 | 20/09/2019 |
| 19/03/2019 | Final | GBP | 0.079 | 18/04/2019 | 23/04/2019 | 29/05/2019 |
| Top Posts |
|---|
Posted at 16/8/2022 13:40 by km18 Genuit posted Interims for the 6 months ended June 30th 2022 this morning. The Group performed reasonably in the HY period with revenues up 7.6% to £318m, PBT down 2.7% to £32.9m and EPS up 27.6% to 10.1p. According to Joe Vorih, CEO, “Agile pricing leadership offset inflationary pressures, and the effect of selective business decisions helped to increase our margins. While mindful of the macroeconomic pressures, we have good momentum as we enter the second half, and the Group anticipates meeting full year expectations.” These are for high single digit revenue growth and widening margins. However, consensus market estimates for FY22 EPS at 33.7p look too aggressive. Valuation is also a little unhelpful with forward PE ratio at 12.4x in the bottom quartile for the sector. Share price is also still in a 12-month correction for now. GEN is a share to monitor for now......from WealthOracle |
Posted at 18/2/2022 13:37 by km18 ...from last year...Company overview: Genuit Group is actually the new name of Polypipe Group plc. They provide sustainable solutions for water, climate and ventilation management. Sustainability is at the core of the firm’s strategy, driven by constant innovations. Genuit benefits from the active plans of governments across the globe to achieve net zero strategies and promote ESG activities and foresees geographic reach to be a major driver of growth for the group in the long term. Blended approach for growth, with several acquisitions and continuous Capex seems to be working for the company in the long run, as both revenues and EPS have been growing steadily over the past 6 years, with the sole exception the catharsis of 2020. Fundamentally the company is also supported by a solid history of debt retirement and cash generation. the half-year report sounds very promising. The group revenue was 32.5% above the 2019 figure (yes, that is a 3rd above the covid free year), driven by a significant raise in residential business at £183.8m (64% growth yoy lfl basis). The sole red flag on the report comes in the face of pressured margins, coming from the rising input costs. This has been balanced very nicely by 8% increase in prices for final customers, which proves the company’s brand recognition. The labour supply issues several sectors are experiencing seems to be fading at Genuit, but we suggest keeping your eyes open for September for further guidance on the direction of the “pingdemic&rdq |
Posted at 29/8/2021 23:13 by philanderer xd thursday morning for the 4p dividend. |
Posted at 21/4/2021 13:50 by philanderer xd tomorrow morning for the 4.8p dividend |
Posted at 02/9/2006 20:10 by rambutan2 yes, the sphere idea crossed my mind. i trawled through the 05 report and accounts earlier today, in part to remind myself why/whether i should still be holding. i decided to hang on in, although as always, was still not convinced that the gen model will ever be really profitable. i think it quite possible that the interims will show a loss. yes, i was struck at how little/no specific info about sgai in the annual report. just in the notes, that it a 63% subsid and that its y/e is 31 march ie different to gen. |
Posted at 02/9/2006 11:49 by rambutan2 interims were 30 august last year. certainly been a keen seller around over recent months - low point being a 100k sale at 8.5p on 29 aug. i think the mms deserve a bonus point for that one!elgordo, perhaps the ace in the pack is going to turn out to be the chinese venture? whatever, the current mkt cap certainly offers good upside if gen do strike some gold. and so it should, as there's lots of catching up to do - gen floated in dec 2000 at 210p! |
Posted at 13/4/2006 20:34 by humpja To double the price of gen would need the 10% of sphere they hold to be rerated to £25m (assuming no dilution in the float). So sphere as a whole needs to be worth at least £250m (10x25) - which seems steep for a company with no sales. Maybe in a few years, but that's still a lot of sensors to shift.Look at CMR - great prospects but because gen has such small holding it isn't likely to set the shareprice on fire. |
Posted at 10/4/2006 14:48 by adejuk sphere will come to aim in or around sept this year. distribution aggrements should be in place and it is set to take blood analysis to a new level - it may well revolutionise hospital practice adn everyone will want this machine.imho gen could double on just that one float. |
Posted at 07/2/2006 11:23 by games anyone know if gen still has a stake in British Titanium, as i see they are claiming $400m from Qinetiq. Bit optimistic, but might raise their profile a bit. |
Posted at 12/12/2005 11:40 by kdwilson I guess that the key impact of this near-term will be to raise GEN's profile. CRM will be seeing lots of institutions who will then also look at GEN. This will lead to interest in other spin offs etc. Still think 20p by March next year possible. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
